Want to see SE:EXPRS2 full AI Analyst Report?
ExpreS2ion Biotech Holding AB (EXPRS2) Stock Forecast & Price Target
EXPRS2 Analyst Ratings
There are no analyst ratings in the last 3 months.
EXPRS2 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | SEK 0.98→SEK 0.89 | hold | -4.50%Downside | Upgraded | 10/31/26 | ||
| Google Health Care EU | TipRanks - Google | SEK 0.98→SEK 0.89 | sell | -5.03%Downside | Reiterated | 10/31/26 | ||
| Anthropic Health Care EU | TipRanks - Anthropic | SEK 0.97→SEK 0.88 | sell | -5.46%Downside | Reiterated | 10/31/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | SEK 0.98→SEK 0.89 | hold | -4.50%Downside | Reiterated | 10/31/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | SEK 0.96→SEK 0.87 | sell | -6.53%Downside | Downgraded | 10/31/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | SEK 0.97→SEK 0.88 | sell | -6.00%Downside | Reiterated | 10/31/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/31/26 | SEK 0.98→SEK 0.89 | hold | -4.50%Downside | Upgraded | TipRanks - PerPlexity | ||
| Google Health Care EU | 10/31/26 | SEK 0.98→SEK 0.89 | sell | -5.03%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Health Care EU | 10/31/26 | SEK 0.97→SEK 0.88 | sell | -5.46%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/31/26 | SEK 0.98→SEK 0.89 | hold | -4.50%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/31/26 | SEK 0.96→SEK 0.87 | sell | -6.53%Downside | Downgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/31/26 | SEK 0.97→SEK 0.88 | sell | -6.00%Downside | Reiterated | TipRanks - xAI |
Best Analysts Covering ExpreS2ion Biotech Holding AB
Copying Google Health Care EU's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +18.57% per trade.
Copying Google Health Care EU's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +24.53% per trade.
Copying Google Health Care EU's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +24.53% per trade.
EXPRS2 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, EXPRS2 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EXPRS2 average Analyst price target in the past 3 months is ―.
EXPRS2 Financial Forecast
EXPRS2 Earnings Forecast
Next quarter’s earnings estimate for EXPRS2 is -SEK 0.27 with a range of ― to ―. The previous quarter’s EPS was -SEK 0.27. EXPRS2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year EXPRS2 has Performed in-line its overall industry.
EXPRS2 Sales Forecast
Next quarter’s sales forecast for EXPRS2 is SEK 2.01M with a range of ― to ―. The previous quarter’s sales results were SEK 2.01M. EXPRS2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year EXPRS2 has Performed in-line its overall industry.